For Patients and Caregivers What is Riabni®?

RIABNI® is a prescription medicine used to treat:1

  • Adults with Non-Hodgkin's Lymphoma (NHL): Alone or with other chemotherapy medicines
  • Adults with Chronic Lymphocytic Leukemia (CLL): With the chemotherapy medicines fludarabine and cyclophosphamide

RIABNI® is a biosimilar medicine1

RIABNI® is a biosimilar of the biologic medicine Rituxan® (rituximab).

RIABNI® was carefully made and thoroughly tested2

RIABNI® is FDA approved as a biosimilar to Rituxan® because it:

  • Is similarly effective
  • Has the same potential side effects
RIABNI (rituximab-arrx) Injection 100mg/vial & 500mg/vial

RIABNI® is made by Amgen, a world leader in biologic MEDICINES WITH 40 YEARS of experience

How RIABNI® works3

Some lymphomas arise when B cells in your body grow unchecked. RIABNI® helps your immune system recognize and destroy these B cells. It’s often called a B-cell–targeted therapy.

CD20
marker
on B cell

 
How does rituximab work
B cells have a protein called CD20 on their surface

RIABNI® can also harm healthy cells in your body.

RIABNI®

 
How does rituximab work
RIABNI® attaches to a CD20 marker on the B cell with cancer and some healthy blood cells

Destroyed B-cell

How does rituximab work
RIABNI® kills B cells and also tells the immune system to HELP FIGHT them

RIABNI® can also harm healthy cells in your body.

Learn about what RIABNI® treats

More
FDA = Food and Drug Admistration.
×
Amgen stands with our local Los Angeles community. Click here to learn what we are doing to support and contact us if the fires have impacted your access to Amgen medication.